Clinical trial
Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of…
NCT00158028 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00158028 |
|---|---|
| Title | Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder |
| Official title | Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | Janssen Pharmaceutica Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizotypal Personality Disorder |
| Intervention type | Drug |
| Interventions | Risperidone, Placebo |
| Enrollment | 25 |
| Start date | Nov 1, 1995 |
| Primary completion | Dec 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: